Showing results (201-210 of 254) with videos related to
Sort By:
Pageof 26
Gut|November 6, 2016
Interplay of host genetics and gut microbiota underlying the onset and clinical presentation of inflammatory bowel diseaseFloris Imhann, Arnau Vich Vila, Marc Jan Bonder, et al.Alimentary Pharmacology & Therapeutics|September 9, 2020
Comorbidity, not patient age, is associated with impaired safety outcomes in vedolizumab- and ustekinumab-treated patients with inflammatory bowel disease-a prospective multicentre cohort studyVera E R Asscher, Vince B C Biemans, Marieke J Pierik, et al.Journal of Crohn'S & Colitis|January 26, 2023
Thioguanine is Effective as Maintenance Therapy for Inflammatory Bowel Disease: A Prospective Multicentre Registry StudyMelek Simsek, Femke Schepers, Sigal Kaplan, et al.Science Translational Medicine|April 25, 2014
Suppression of p21Rac signaling and increased innate immunity mediate remission in Crohn's diseaseKaushal Parikh, Lu Zhou, Rajesh Somasundaram, et al.European Journal of Gastroenterology & Hepatology|December 5, 2022
Retreatment with anti-tumor necrosis factor therapy in combination with an immunomodulator for recurrence of Crohn's disease after ileocecal resection results in prolonged continuation as compared to anti-tumor necrosis factor monotherapySebastiaan Ten Bokkel Huinink, Evelien M J Beelen, Thomas Ten Bokkel Huinink, et al.Lancet (London, England)|July 19, 2017
Telemedicine for management of inflammatory bowel disease (myIBDcoach): a pragmatic, multicentre, randomised controlled trialMarin J de Jong, Andrea E van der Meulen-de Jong, Mariëlle J Romberg-Camps, et al.The American Journal of Gastroenterology|September 22, 2023
Prognostic Value of the Modified Rutgeerts Score for Long-Term Outcomes After Primary Ileocecal Resection in Crohn's DiseaseMichiel T J Bak, Sebastiaan Ten Bokkel Huinink, Nicole S Erler, et al.BJS Open|September 29, 2023
Impact of timing of primary ileocecal resection on prognosis in patients with Crohn's diseaseEvelien M J Beelen, Jeanine H C Arkenbosch, Nicole S Erler, et al.Immunity|May 10, 2023
Phage-display immunoprecipitation sequencing of the antibody epitope repertoire in inflammatory bowel disease reveals distinct antibody signaturesArno R Bourgonje, Sergio Andreu-Sánchez, Thomas Vogl, et al.Gut|October 23, 2013
Treatment of bone loss in osteopenic patients with Crohn's disease: a double-blind, randomised trial of oral risedronate 35 mg once weekly or placebo, concomitant with calcium and vitamin D supplementationAd A van Bodegraven, Nathalie Bravenboer, Birgit I Witte, et al.Pageof 26